 TORONTO, Sept. 08, 2022 GLOBE NEWSWIRE -- Reunion Neuroscience Inc. TSX: REUN, Nasdaq: REUN Reunion, or the Company, a global leader in the discovery and development of innovative psychedelic-inspired therapeutics for improved mental health outcomes, today announced it will participate in two upcoming investor conferences in September 2022. 